Testing a new gel for moderate to severe melasma
Part of Skin clinical trials.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old with moderate to severe melasma that has been stable for at least 3 months.
- You must be willing to apply a study gel to your face and use only the provided sunscreen, moisturizer, and cleanser.
- You need to stop using other skin-lightening or anti-aging creams for the duration of the study.
- Women who can become pregnant must use reliable birth control (like pills, IUD, or abstinence) and not change it during the study.
- You should avoid excessive sun exposure and tanning, and you must apply the study sunscreen daily.
- You cannot have other skin conditions (like eczema, psoriasis, or vitiligo) on your face, or have used certain treatments (like lasers, peels, or bleaching creams) recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called tranexamic acid, taken as a pill or used on the skin, can help fade melasma in women with darker skin types. It aims to find a safe way to improve skin color and is relevant to those looking for new melasma treatment options. The trial compares the treatment to another study treatment without medicine. Participation is open to women aged 30 to 60 with darker skin tones who are not pregnant and are not using certain other skin or hormone treatments.
This study compares two different combination creams for treating melasma, a common skin condition causing dark patches on the face. One cream includes a mild steroid and the other has a different steroid, both with the same lightening ingredients. The goal is to see which works better and is safer for your skin.
This trial tests a new gel applied to the skin that combines three ingredients to treat melasma, a condition causing dark patches on the face. It may help lighten these patches and improve skin appearance.
This study tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for different types of dark skin patches (like melasma, dark marks after acne, or sun spots). Participants will have several treatments and be monitored for about a few months.
This trial tests a serum with ingredients like niacinamide to improve dark spots from acne and melasma, used alongside a laser treatment. It aims to see if the serum makes the laser more effective at lightening skin patches.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.